Midodrine Exclusivity Issues

 
Docket ID: FDA-2007-N-0475
Agency: Food and Drug Administration (FDA)
Parent Agency: Department of Health and Human Services (HHS)
Docket Details open glossary dialog  
Related RINs: None
Related Dockets: None
Short Title: Midodrine Exclusivity Issues
Keyword(s): Exclusivity Issues, Midodrine , CDER
Legacy ID: 2007N-0311
Type: Nonrulemaking
Docket Status: OPEN
Center: CDER
Docket Item Code: N
 

Primary Documents

View All  (15)
Comment Period Closed
Other
Posted: 09/19/2014
ID: FDA-2007-N-0475-0040
Comment Period Closed
Other
Posted: 08/26/2014
ID: FDA-2007-N-0475-0039
Comment Period Closed
Other
Posted: 01/24/2012
ID: FDA-2007-N-0475-0037
Comment Period Closed
Other
Posted: 01/13/2012
ID: FDA-2007-N-0475-0036
Comment Period Closed
Other
Posted: 12/22/2011
ID: FDA-2007-N-0475-0035

Supporting Documents

View All  (3)
Comments Not Accepted
Supporting & Related Material
Posted: 10/04/2010
ID: FDA-2007-N-0475-0029
Comments Not Accepted
Supporting & Related Material
Posted: 10/04/2010
ID: FDA-2007-N-0475-0030
Comments Not Accepted
Supporting & Related Material
Posted: 10/04/2010
ID: FDA-2007-N-0475-0028

Comments

View All  (23)

66
Comments Received*
*This count refers to the total comment/submissions received on this docket, as of 11:59 PM yesterday. Note: Agencies review all submissions, however some agencies may choose to redact, or withhold, certain submissions (or portions thereof) such as those containing private or proprietary information, inappropriate language, or duplicate/near duplicate examples of a mass-mail campaign. This can result in discrepancies between this count and those displayed when conducting searches on the Public Submission document type. For specific information about an agency’s public submission policy, refer to its website or the Federal Register document.